ARCHIVES

Rauscher Says He May Leave, But Will Stay Through June

This article is from The Cancer Letter archive.

Vol. 02 No. 06 | February 6, 1976

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Grant Funding: The History Of a Controversy

July 23, 1993

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored

April 25, 1992

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990